CRIS Current Research Information System

MANFREDI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.656
AS - Asia 17.956
EU - Europa 17.892
SA - Sud America 1.359
AF - Africa 934
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 57.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.409
GB - Regno Unito 5.499
CN - Cina 5.277
SG - Singapore 4.795
VN - Vietnam 3.977
IT - Italia 2.562
UA - Ucraina 2.301
DE - Germania 2.289
FR - Francia 1.324
SE - Svezia 1.300
HK - Hong Kong 1.149
RU - Federazione Russa 1.023
IN - India 1.021
BR - Brasile 970
IE - Irlanda 519
JP - Giappone 497
ZA - Sudafrica 360
EE - Estonia 337
KR - Corea 324
NL - Olanda 225
SC - Seychelles 214
BD - Bangladesh 208
AR - Argentina 164
FI - Finlandia 151
CI - Costa d'Avorio 134
CA - Canada 124
ID - Indonesia 100
PH - Filippine 98
TG - Togo 98
TH - Thailandia 97
IQ - Iraq 63
MX - Messico 59
EC - Ecuador 58
TR - Turchia 53
GR - Grecia 52
CH - Svizzera 49
CO - Colombia 43
BG - Bulgaria 41
LB - Libano 37
MY - Malesia 37
PL - Polonia 35
PY - Paraguay 34
AT - Austria 32
JO - Giordania 32
CL - Cile 31
TW - Taiwan 29
SA - Arabia Saudita 28
UZ - Uzbekistan 28
PK - Pakistan 27
BE - Belgio 26
VE - Venezuela 25
ES - Italia 24
MA - Marocco 22
PE - Perù 21
KE - Kenya 19
AU - Australia 18
ET - Etiopia 16
RO - Romania 16
IR - Iran 15
CZ - Repubblica Ceca 14
EG - Egitto 14
JM - Giamaica 12
TN - Tunisia 12
LT - Lituania 11
HU - Ungheria 10
CR - Costa Rica 9
NG - Nigeria 9
NP - Nepal 9
SK - Slovacchia (Repubblica Slovacca) 9
DO - Repubblica Dominicana 8
PS - Palestinian Territory 8
DZ - Algeria 7
KZ - Kazakistan 7
SI - Slovenia 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
IL - Israele 6
PT - Portogallo 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
NI - Nicaragua 5
OM - Oman 5
RS - Serbia 5
BS - Bahamas 4
DK - Danimarca 4
EU - Europa 4
GT - Guatemala 4
HN - Honduras 4
KG - Kirghizistan 4
AO - Angola 3
AZ - Azerbaigian 3
BY - Bielorussia 3
HR - Croazia 3
PA - Panama 3
PR - Porto Rico 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
Totale 57.769
Salva come PNG Salva come JPEG
Città #
Southend 4.922
Singapore 3.109
Jacksonville 1.677
Fairfield 1.531
Ashburn 1.516
Hong Kong 1.103
Hefei 1.045
Chandler 1.008
Wilmington 943
Princeton 936
Dong Ket 901
Santa Clara 838
Woodbridge 752
San Jose 727
Ho Chi Minh City 683
Houston 649
Seattle 647
Hanoi 585
Boardman 548
Council Bluffs 543
Lauterbourg 541
Cambridge 540
Dublin 513
Nanjing 478
Tokyo 463
Ann Arbor 455
Westminster 454
Padova 449
Beijing 408
Bologna 380
Berlin 339
Los Angeles 324
Seoul 291
Milan 266
Mülheim 255
Dallas 247
Saint Petersburg 222
Buffalo 221
Jinan 214
Shenyang 199
Mahé 196
Medford 191
Hebei 148
Nanchang 140
Changsha 138
Helsinki 136
Abidjan 134
The Dalles 134
San Diego 127
New York 119
Tianjin 117
Verona 116
Rome 109
Haiphong 106
Redondo Beach 100
Lomé 98
Des Moines 90
São Paulo 88
Da Nang 85
Jiaxing 84
Zhengzhou 82
Guangzhou 81
Hangzhou 81
Phoenix 77
Shanghai 76
Dearborn 70
Chicago 68
Kunming 66
Yubileyny 66
Bengaluru 64
San Francisco 61
Bangkok 59
Redmond 59
Norwalk 58
Olalla 57
Ningbo 54
Frankfurt am Main 53
Falls Church 52
Lanzhou 46
London 46
Haikou 45
Rio de Janeiro 42
Ingolstadt 39
Jakarta 39
Biên Hòa 38
Turin 38
Wuhan 38
Hải Dương 36
Sofia 36
Bühl 35
Redwood City 35
Taizhou 35
Amman 32
Orem 32
Can Tho 31
Florence 31
Fuzhou 28
Montreal 28
Taiyuan 27
Naples 26
Totale 36.345
Salva come PNG Salva come JPEG
Nome #
Update on the appropriate use of linezolid in clinical practice 575
The destiny of italian prisoners in austro-hungarian pow camps during the first world war: Remembering the defeat of caporetto 100 years on 309
Candidosi esofagea ricorrente in corso di infezione da HIV non associata ad evidente stato di immunodeficienza, ed in presenza di un trattamento antiretrovirale efficace 280
The plague which hit the city of Bologna in the year 1630 276
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. 244
Acute onset myopericarditis as unusual presentation of primary HIV infection 238
Turicella otitidis central venous-related bacteremia during pediatric acute lymphoblastic leukemia 224
Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapy 221
A 2-year survey of bacteriologic profile and antimicrobial susceptibility levels of Enterococci in a large Italian teaching hospital. 217
Admission of foreign citizens to the general teaching hospital of Bologna, northeastern Italy: an epidemiological and clinical survey 217
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. 213
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 205
Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection. 198
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 196
Fatal long-term immunosuppressive therapy with uncontrolled repeat prescription 195
Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis 193
Abacavir-induced febrile agranulocytosis and anaemia. 193
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 192
Causes of hospitalization among Extra-European Union children in a large Hospital of Northern Italy, in a five-year observation period 191
Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management 191
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia. 189
Diffusa disseminazione cutanea di una leishmaniosi viscerale in corso di infezione da HIV: un percorso diagnostico e terapeutico. 187
Basic clinical-applied pharmacoeconomic features of antiretroviral therapy. A pilot single-centre study performed on around 1000 HIV-infected individuals receiving combined antiretroviral treatment 186
A novel antiretroviral class (fusion inhibitors) in the management of HIV infection. Present features and future perspectives of enfuvirtide (T-20) 186
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 186
Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. 185
Atypical progressive multifocal leukoencephalopathy in HIV with a high CD4 count: the use of magnetic resonance imaging plus spectrometry studies 182
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues 182
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitors: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mmc) 181
Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. 181
Chronic hepatitis with diffuse steatosis and slight fibrosis related to etretinate therapy 178
Management of Strongyloides stercoralis extensive infestation in a patient with Sjogren syndrome 178
Pancreotoxicity of propofol sedation during purulent meningitis. 176
Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological, and imaging response of lung tuberculosis to specific treatment. Which role for linezolid? 176
Insulin resistance and diabetes mellitus in HIV-infected patients receiving antiretroviral therapy 175
La peste di Giustiniano (prima parte) 175
Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management 174
A puzzling microbiological and clinical discrepancy in the management of acute, severe skin-soft tissue and joint staphylococcal infection. In vitro antimicrobial susceptibility to glycopeptides, versus in vivo clinical efficacy of linezolid alone 174
Abdominal neoplasia with sarcomatoid features as the presenting illness of a patient with a newly diagnosed HIV infection and no AIDS-related disorders. Case report, clinical and diagnostic features, and literature discussion 174
Measles outbreak in the city of Bologna, December 2007 to May 2008 172
Protease inhibitor monotherapy as maintenance regimen in patients with HIV infection. 172
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy 172
A prospective comparison of hepatotoxicity of the two currently available non-nucleoside reverse transcriptase inhibitors in a homogeneous case-mix of HIV-infected patients treated for the first time with efavirenz or nevirapine, according to their different baseline conditions 170
Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk. 170
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. 170
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 170
Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones. 169
Georges Canguilhem. Sulla Medicina. Scritti 1955-1989, Einaudi, 2007 168
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS 168
A very particular case of long-term non-progressor: nineteen consecutive years of follow-up in the absence of any detectable HIV-1 viraemia 167
Liposomal amphotericin B and HIV-associated visceral leishmaniasis: concerns about nephrotoxicity and administration schedule 166
Long-term "self-managed" immunosuppressive treatment resulting in death due to fulminant hepatitis B 165
Bone mass loss in patients with human immunodeficiency virus type 1 infection: association with male sex and protease inhibitor therapy 165
Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy 165
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir 165
Candida albicans panuveitis and an uneven therapeutic ground, passing through all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole 164
Kidney failure during HIV disease treated with tenofovir, multiple concurrent diseases and drug therapies 164
Abacavir-lamivudina versus tenofovir-emtricitabina più atazanavir-ritonavir nella semplificazione dell'HAART per dislipidemia 164
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 163
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. 163
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine 163
Aggressive, metastatic squamous cell carcinoma after a 46-year-old history of chronic osteomyelitis and local infectious complications: a case report 163
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure 162
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study. 161
Antibodies reactive with C-terminus of the second conserved region of HIV-1 gp120 as possible prognostic marker and therapeutic agent for HIV disease 161
Methicillin-resistant staphylococci still susceptible to non-beta-lactam antibiotics. What clinical implications in nosocomially-acquired infections? 160
Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study. 160
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors. 160
Legionnaires' disease associated with macular rash: two cases 159
Novel pharmaceutical molecules against emerging resistant gram-positive cocci 159
Severe peripheral neuropathy with areflexic and flaccid quadriplegia complicating Legionnaires’ disease in an adult patient. 159
Polyunsaturated ethyl esters on n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy. 157
Loss of bone mass in chronically HIV-infected patients. Significant association with male gender and protease inhibitor administration 157
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection. 157
First-line efavirenz versus lopinavir/ritonavir-based highly active antiretroviral therapy for naïve patients. 156
Neurosyphilis in a young adult: very early tertiary syphilis? 156
Primary Cytomegalovirus infection in otherwise healthy adults with Fever of Unknown Origin: a 3-year prospective survey 156
Malaria infection and the anthropological evolution 156
Severe Community - Acquired Achromobacter denitrificans Cellulitis 155
An observational study of subcutaneous multiple lipomatosis in patients receiving highly active antiretroviral therapy. Possible correlations with metabolic abnormalities and pathogenetic insights 155
Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy. 154
Aderenza alla terapia antiretrovirale "autogestita" dai pazienti alla metà della posologia giornaliera raccomandata. Inattesa efficacia immunologica e virologica a lungo termine 154
Antiretroviral therapy voluntarily taken at half-dosage, but fully effective after 6-10 years: a provocative issue for adherence requirements. Case report 153
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy. 153
Patomorfosi della tubercolosi polmonare: studio osservazionale sulla risposta clinica, batteriologica, e dell'imaging alle terapie specifiche. Quale ruolo per linezolid? 152
Tuberculosis in a metropolitan area of northern Italy: epidemiological trends and public health concerns 150
Un "AIDS Presenter" seguito per oltre venti anni con un'infezione da HIV clinicamente e laboratoristicamente stabile, a dispetto della mancata o irregolare assunzione della terapia antiretrovirale 150
Community-acquired pneumonia and sepsis caused by a multiresistant Staphylococcus aureus strain resulting in a severe and long-lasting multiple organ inflammatory involvement 150
A patient with a 12-year history characterized by four non-AIDS-related malignancies, occurring before and after the disclosure of HIV infection 149
Antiretroviral treatment and gynecomastia: which correlations? 147
Comparison between switching therapy from protease inhibitors to an NNRTI and lipid-lowering therapy with pravastatin or bezafibratef for the management of HAART-related dyslipidemia 147
Changing epidemiology of hepatitis A in the Bologna metropolitan area, northern Italy: importance of counselling and prophylactic measures for the male homo/bisexual population. 147
Multiple, severe lung infiltrates due to Mycobacterium avium-intracellulare in a patient with decompensated liver cirrhosis: spontaneous resolution after a two-year follow-up 147
Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study. 147
Diffuse skin spread of HIV-associated visceral leishmaniasis: cumbersome diagnostic and therapeutic issues 146
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia 146
Safety issues about nevirapine administration in HIV-infected pregnant women 145
AIDS: esiste ancora? Storia e Prevenzione 145
Tubercular disease caused by Bacillus of Calmette-Guérin as a local adjuvant treatment of relapsing bladder carcinoma 145
In vitro antimicrobial sensitivity trends of Enterococci isolated at an Italian teaching hospital. A 2004-2007 prospective report including over 2,700 examined microbial strains 145
Totale 17.849
Salva come PNG Salva come JPEG
Categoria #
all - tutte 160.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.472
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.973 780 380 439 685 645 477 116 468 216 347 1.170 1.250
2022/20235.626 735 882 352 681 343 328 191 269 937 160 580 168
2023/20241.201 100 241 101 101 87 159 82 71 43 111 51 54
2024/20257.001 155 1.576 763 521 1.444 314 394 105 79 253 96 1.301
2025/202616.782 815 1.663 2.162 1.606 1.936 1.094 1.216 537 2.737 1.493 607 916
2026/2027262 262 0 0 0 0 0 0 0 0 0 0 0
Totale 58.687